Adverse events associated with acupuncture: three multicentre randomized controlled trials of 1968 cases in China
Zhao et al. · Trials · 2011
Evidence Level
STRONGOBJECTIVE
Assess acupuncture safety through adverse event monitoring across three multicenter clinical trials
WHO
1,968 patients with migraine, functional dyspepsia, and Bell's palsy
DURATION
4 weeks of treatment with 3 months of follow-up
POINTS
Standardized points specific to each condition: Fengchi (GB-20), Yangbai (GB-14), Dicang (ST-4), among others
🔬 Study Design
Migraine
n=475
Standardized acupuncture with electrostimulation
Functional Dyspepsia
n=593
Standardized acupuncture with electrostimulation
Bell's Palsy
n=900
Semi-standardized acupuncture with/without electrostimulation
📊 Results in numbers
Adverse event rate
Patients with full recovery
Dropouts due to adverse events
Serious adverse events
Recovery time
Percentage highlights
📊 Outcome Comparison
Most common types of adverse events
This large Chinese study of nearly 2,000 patients showed that acupuncture is very safe, with only 3.76% of patients experiencing mild side effects such as minor bleeding or hematoma. Practically all patients recovered fully within two weeks, and no serious events were recorded.
Article summary
Plain-language narrative summary
This important multicenter observational study analyzed the safety of acupuncture in 1,968 patients treated at 16 hospitals in five Chinese provinces between December 2007 and October 2009. The investigators monitored adverse events across three distinct randomized controlled clinical trials: one for migraine (475 patients), another for functional dyspepsia (593 patients), and a third for Bell's palsy (900 patients). All participants received acupuncture treatment for four weeks, totaling 20 sessions, followed by three months of follow-up. The acupuncturists involved had at least eight years of training in acupuncture and were physicians qualified in Traditional Chinese Medicine, or associate physicians with more than ten years of clinical experience.
Sterile single-use needles were used to avoid cross infections, and all practitioners underwent specific training on the study protocols before initiating treatments. The results demonstrated that acupuncture is a safe therapy, with a low risk of adverse events. Of the 1,968 patients monitored, only 74 (3.76%) experienced at least one adverse event throughout the treatment period. No serious adverse events were observed, such as organ injury or neurological damage.
The most common adverse events were bleeding at the puncture site (37.84%) and subcutaneous hematoma (25.68%), followed by skin ecchymosis and pain at the needle site. Notably, 73 of the 74 patients who experienced adverse events recovered fully within two weeks through effective treatment, including physical therapy, self-treatment, or other effective methods. Only three patients withdrew from the study due to adverse events. Logistic regression analysis revealed that age and sex were risk factors for acupuncture-related adverse events.
Older patients had a higher risk of adverse events, and male patients had a slightly higher risk than female patients. The investigators identified that the types of adverse events were related to the location and anatomical structure of the acupuncture points used. For example, in the treatment of Bell's palsy, which involves facial points where the skin is thin and rich in blood vessels, subcutaneous hematoma was more common. In migraine treatment, which uses points in the cranial region with abundant vascular supply, bleeding at the puncture site was more frequent.
The study also highlighted the importance of an appropriate medical setting, the high technical level of the acupuncturists, and the establishment of a strong mutual trust relationship between physician and patient in reducing the occurrence of adverse events. The clinical implications are significant, as they provide robust evidence that acupuncture, when performed by qualified professionals in an appropriate hospital setting, is a very safe therapy. The 3.76% adverse event rate found in this study falls within the range reported in international studies (0.67% to 11.4%) and all events were mild and temporary.
Strengths
- 1Large sample of 1,968 patients in a multicenter study
- 2Systematic and rigorous monitoring of adverse events
- 3Highly qualified acupuncturists with at least 8 years of training
- 4Use of sterile single-use needles in a hospital setting
- 5Robust statistical analysis of risk factors
Limitations
- 1Study limited to only three specific clinical conditions
- 2Conducted only in China, which may introduce cultural variations
- 3Two-thirds of the data came from efficacy studies, not specifically safety studies
- 4Limited analysis of demographic factors and adverse event details
Expert Commentary
Dr. Marcus Yu Bin Pai
MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture
▸ Clinical Relevance
The safety profile documented here has direct weight in the conversation we have daily with patients and with colleagues who are skeptical about the use of acupuncture in formal clinical settings. With 1,968 participants distributed across three conditions — migraine, functional dyspepsia, and Bell's palsy — and systematic monitoring over four weeks of treatment and three months of follow-up, the data allow us to state with reasonable certainty that the rate of clinically relevant adverse events is low. Only 74 patients (3.76%) experienced any event, all of a local and transient nature. Zero serious events. This has direct implications for indications in populations we habitually decline due to presumed fragility — older adults on low-dose anticoagulation, patients in post-stroke rehabilitation, individuals with multiple comorbidities who have limited pharmacological options. The risk analysis by anatomical point location reinforces the importance of technical planning of the session, not merely candidate selection.
▸ Notable Findings
Two findings deserve special attention. First, the almost universal resolution of adverse events: 73 of the 74 cases recovered fully within two weeks, with only three discontinuations across nearly two thousand exposures — a proportion that many drugs in routine use for pain and neurology would not match in a comparable context. Second, the relationship between type of adverse event and the anatomical architecture of the point used is clinically instructive. Facial points used for Bell's palsy, with thin skin and rich vascularization, generated a predominance of subcutaneous hematoma; cranial points for migraine, with abundant circulation, were more associated with local bleeding. This topography of risk is not trivial: it guides technical decisions on angulation, depth, and post-puncture pressure. The identification of advanced age and male sex as independent — albeit modest — risk factors opens space for pre-session stratification.
▸ From My Experience
In my practice at the pain and rehabilitation clinic, the 3.76% mild adverse event figure is fully consistent with what we observe — and, in most weeks, we are below that. Post-puncture hematoma in the facial and temporal regions is the event I see most often, especially in patients over 65 on aspirin. In this profile, I instruct immediate compression for 60 to 90 seconds and reduce needle gauge; I rarely need to suspend the session. In terms of clinical response, I typically see the first signs of functional improvement between the third and fifth session in the treatment of conditions such as chronic migraine and temporomandibular disorders, and I work with cycles of eight to twelve sessions for consolidation before spacing to monthly maintenance. The study validates something that already guides my practice: safety is not inherent to the technique in the abstract, but to the whole set — technical qualification of the physician, appropriate point selection, and a hospital environment with sterile supplies. I never delegate that assessment.
Full original article
Read the full scientific study
Trials · 2011
DOI: 10.1186/1745-6215-12-87
Access original articleScientific Review

Marcus Yu Bin Pai, MD, PhD
CRM-SP: 158074 | RQE: 65523 · 65524 · 655241
PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.
Learn more about the author →Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.
Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.
Related articles
Based on this article’s categories